Drug Shortage Report for MYLAN-MIRTAZAPINE
Report ID | 166037 |
Drug Identification Number | 02256096 |
Brand name | MYLAN-MIRTAZAPINE |
Common or Proper name | MIRTAZAPINE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | MIRTAZAPINE |
Strength(s) | 15MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-09-09 |
Actual start date | 2022-09-09 |
Estimated end date | 2023-05-09 |
Actual end date | 2023-05-09 |
Shortage status | Resolved |
Updated date | 2023-10-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v34 | 2023-10-03 | French | Compare |
v33 | 2023-10-03 | English | Compare |
v32 | 2023-10-03 | French | Compare |
v31 | 2023-10-03 | English | Compare |
v30 | 2023-10-03 | French | Compare |
v29 | 2023-10-03 | English | Compare |
v28 | 2023-05-08 | French | Compare |
v27 | 2023-05-08 | English | Compare |
v26 | 2023-04-04 | French | Compare |
v25 | 2023-04-04 | English | Compare |
v24 | 2023-03-27 | French | Compare |
v23 | 2023-03-27 | English | Compare |
v22 | 2023-03-20 | French | Compare |
v21 | 2023-03-20 | English | Compare |
v20 | 2023-02-28 | French | Compare |
v19 | 2023-02-28 | English | Compare |
v18 | 2023-02-23 | French | Compare |
v17 | 2023-02-23 | English | Compare |
v16 | 2023-02-14 | French | Compare |
v15 | 2023-02-14 | English | Compare |